Back to Market返回行情
CU
CURA.TO Curaleaf Holdings, Inc.
TSXHealthcare$16.21+6.57%ClosedMarket Cap: $3.77B
As of 2026-06-05 16:00
Valuation
P/E (TTM)
-27.41
PEG
—
P/B
3.43
P/S
2.16
EV/EBITDA
19.85
DCF Value
—
FCF Yield
1.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
40.8%
Operating Margin
0.9%
Net Margin
-7.9%
ROE
-12.6%
ROA
-3.7%
ROIC
0.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $318.9M | 38.1% | $740.7K | $68.7M | $0.27 | — |
| Q4 2025 | $338.2M | 38.0% | $3.0M | $-60.7M | $-0.24 | — |
| Q3 2025 | $320.2M | 49.9% | $4.0M | $-57.0M | $-0.23 | — |
| Q2 2025 | $314.5M | 48.5% | $3.3M | $-65.0M | $-0.24 | — |
| Q1 2025 | $310.0M | 50.1% | $7.8M | $-61.1M | $-0.21 | — |
| Q4 2024 | $331.1M | 47.5% | $-9.3M | $-77.6M | $-0.30 | — |
| Q3 2024 | $330.5M | 48.6% | $9.2M | $-40.7M | $-0.16 | — |
| Q2 2024 | $342.3M | 36.2% | $7.5M | $-48.9M | $-0.20 | — |
| Q1 2024 | $337.4M | 36.8% | $12.6M | $-48.1M | $-0.20 | — |
| Q4 2023 | $354.8M | 34.3% | $14.4M | $-65.0M | $-0.27 | — |
| Q3 2023 | $333.2M | 45.0% | $15.2M | $-92.3M | $-0.39 | — |
| Q2 2023 | $335.6M | 44.0% | $-4.3M | $-71.2M | $-0.30 | — |